This is a revised application for Project by Caligiuri. The proposed Project will test specific hypotheses in regard to the effects of METH and HIV, singly and in combination, on neuromotor function. The Project will also explore the possible added effects of HCV. Methamphetamine (METH) exerts powerful influences on brain systems regulating sensorimotor functions. Movement disorders associated with chronic METH use may stem from a neurotoxic mechanism involving reduction in dopamine and/or a disinhibition mechanism related to reduction in enkephalin/GABA mediated inhibition. If the neurotoxicity mechanism is correct, we would hypothesize that the movement disorder would take the form of parkinsonism and would persist through periods of abstinence. However, if basal ganglia pathways mediating response inhibition are involved, the movement disorder would manifest as motor disinhibition. These effects of METH need to be understood in the context of risk that METH abusers face of infection by HIV and HCV. The former is known to cause brain disease, and recent evidence also suggests HCV may infect the brain. We plan to utilize quantitative instrumental measures of parkinsonism and motor disinhibition. The within-project aims are to: (1) systematically delineate the specific types of motor disturbances associated with HIV and METH abuse;(2) evaluate whether longer periods of abstinence from METH use are associated with improvement in the severity of neuromotor disturbance among chronic METH abusers, and examine moderators of this process (e.g., HCV);and (3) clarify potential interactions between the neuromotor and neurocognitive disturbances associated with METH abuse and HIV by assessing whether subjects who are cognitively impaired also exhibit neuromotor disturbances. This Project will function synergistically with each of the other Projects by linking the patterns of movement disorders that are thought to reflect specific neural circuitries to the anatomic, mechanistic, and cognitive information from other Projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012065-10
Application #
7812242
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
10
Fiscal Year
2009
Total Cost
$11,333
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Marquine, María J; Flores, Ilse; Kamat, Rujvi et al. (2018) A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neurovirol 24:549-556
Dufour, Catherine A; Marquine, María J; Fazeli, Pariya L et al. (2018) A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults. AIDS Behav 22:1562-1572
Oppenheim, Hannah; Paolillo, Emily W; Moore, Raeanne C et al. (2018) Neurocognitive functioning predicts frailty index in HIV. Neurology 91:e162-e170
Paolillo, Emily W; Gongvatana, Assawin; Umlauf, Anya et al. (2017) At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res 41:1518-1525
Marquine, María J; Montoya, Jessica L; Umlauf, Anya et al. (2016) The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis 63:694-702
Soontornniyomkij, Virawudh; Kesby, James P; Morgan, Erin E et al. (2016) Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. J Neuroimmune Pharmacol 11:495-510
Bharti, Ajay R; McCutchan, Allen; Deutsch, Reena et al. (2016) Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults. Clin Infect Dis 63:1655-1660
Bharti, Ajay R; Woods, Steven Paul; Ellis, Ronald J et al. (2016) Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV AIDS (Auckl) 8:93-9
Marquine, M J; Sakamoto, M; Dufour, C et al. (2016) The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons. J Neurovirol 22:442-54
Ma, Qing; Vaida, Florin; Wong, Jenna et al. (2016) Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol 22:170-8

Showing the most recent 10 out of 132 publications